| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 44.54 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : 0.04 |
EPS(TTM) : 54.76 |
|
Book Value(₹) : 397.02 |
Market Cap(₹Cr) : 100,729.72 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,964.05 | 2,581.82 | 2,632.68 | 2,608.78 | 2,569.73 | 2,119.46 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,964.05 | 2,581.82 | 2,632.68 | 2,608.78 | 2,569.73 | 2,119.46 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 33.96 | 126.70 | 56.52 | 77.67 | 65.21 | 219.51 |
| Total Income | 2,998.01 | 2,708.52 | 2,689.20 | 2,686.45 | 2,634.94 | 2,338.97 |
| Total Expenditure | 2,035.47 | 1,685.80 | 1,937.86 | 1,915.59 | 1,884.80 | 1,777.62 |
| PBIDT | 962.54 | 1,022.72 | 751.34 | 770.86 | 750.14 | 561.35 |
| Interest | 94.95 | 125.28 | 138.37 | 147.20 | 149.34 | 162.12 |
| PBDT | 867.59 | 897.44 | 612.97 | 623.66 | 600.80 | 399.23 |
| Depreciation | 111.02 | 109.43 | 107.68 | 99.03 | 104.63 | 114.78 |
| Tax | 165.34 | 161.98 | 121.56 | 97.54 | 92.14 | 93.07 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 32.74 | -87.58 | -65.15 | -31.81 | -11.24 | -46.78 |
| Reported Profit After Tax | 558.49 | 713.61 | 448.88 | 458.90 | 415.27 | 238.16 |
| Extra-ordinary Items | 0.00 | -18.13 | -63.36 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 558.49 | 731.74 | 512.24 | 458.90 | 415.27 | 238.16 |
| EPS (Unit Curr.) | 13.53 | 17.29 | 10.87 | 11.12 | 10.00 | 5.70 |
| EPS (Adj) (Unit Curr.) | 13.53 | 17.29 | 10.87 | 11.12 | 10.00 | 5.70 |
| Calculated EPS (Unit Curr.) | 13.52 | 17.29 | 10.87 | 11.12 | 10.06 | 5.77 |
| Calculated EPS (Adj) (Unit Curr.) | 13.52 | 17.29 | 10.87 | 11.12 | 10.06 | 5.77 |
| Calculated EPS (Ann.) (Unit Curr.) | 54.09 | 69.15 | 43.50 | 44.47 | 40.26 | 23.09 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 54.09 | 69.15 | 43.50 | 44.47 | 40.26 | 23.09 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 100.00 | 100.00 | 0.00 |
| Equity | 41.30 | 41.28 | 41.28 | 41.28 | 41.26 | 41.26 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 32.47 | 39.61 | 28.54 | 29.55 | 29.19 | 26.49 |
| PBDTM(%) | 29.27 | 34.76 | 23.28 | 23.91 | 23.38 | 18.84 |
| PATM(%) | 18.84 | 27.64 | 17.05 | 17.59 | 16.16 | 11.24 |
